Toshifumi Ozaki Selected Research

Giant Cell Tumor of Bone

9/2022	A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
5/2022	Current management of giant-cell tumor of bone in the denosumab era.
4/2019	A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.
8/2018	Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshifumi Ozaki Research Topics

Disease

66	Neoplasms (Cancer) 04/2024 - 02/2002
39	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 03/2002
27	Pain (Aches) 01/2024 - 09/2008
25	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2003
23	Osteosarcoma (Osteogenic Sarcoma) 05/2022 - 02/2002
20	Rheumatoid Arthritis 02/2024 - 05/2003
14	Osteoarthritis 02/2024 - 05/2003
11	Synovial Sarcoma (Synovioma) 04/2021 - 09/2003
10	Congenital Abnormalities (Deformity) 02/2024 - 01/2016
9	Margins of Excision 11/2023 - 01/2003
9	Scoliosis 01/2017 - 12/2007
8	Infections 08/2022 - 03/2002
6	Wounds and Injuries (Trauma) 08/2022 - 01/2015
6	Paralysis (Palsy) 11/2021 - 09/2008
5	Neurofibrosarcoma (MPNST) 03/2024 - 09/2012
5	Hip Osteoarthritis (Coxarthrosis) 05/2023 - 01/2015
5	Hip Fractures (Intertrochanteric Fractures) 06/2022 - 01/2020
5	Chondrosarcoma 11/2020 - 02/2003
4	Ewing Sarcoma (Sarcoma, Ewing) 03/2023 - 05/2002
4	Giant Cell Tumor of Bone 09/2022 - 08/2018
4	Spinal Cord Injuries (Spinal Cord Injury) 12/2019 - 03/2005
3	Alveolar Soft Part Sarcoma 11/2023 - 04/2021
3	Liposarcoma 03/2023 - 11/2011
3	Anemia 10/2022 - 01/2015
3	Giant Cell Tumors (Giant Cell Tumor) 09/2022 - 11/2011
3	Femoral Fractures (Femoral Fracture) 06/2022 - 07/2021
3	Breast Neoplasms (Breast Cancer) 02/2022 - 09/2014
3	Aggressive Fibromatosis (Desmoid) 05/2020 - 01/2019
3	Osteoporosis 03/2018 - 01/2009
3	Leukemia 11/2017 - 05/2002
3	Hemorrhage 04/2016 - 01/2015
3	Kyphosis 01/2016 - 06/2011
3	Spinal Cord Diseases 01/2016 - 05/2007
3	Low Back Pain (Lumbago) 01/2016 - 03/2014
3	Venous Thromboembolism 01/2015 - 01/2015
3	Carcinogenesis 01/2013 - 09/2003
2	Knee Injuries (Knee Injury) 02/2024 - 09/2023
2	Weight Gain 01/2024 - 05/2020
2	Developmental Dysplasia of the Hip 12/2023 - 08/2009
2	Knee Osteoarthritis 10/2023 - 11/2019
2	Femoral Neck Fractures 12/2022 - 02/2021

Drug/Important Bio-Agent (IBA)

13	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 05/2005
12	MicroRNAs (MicroRNA)IBA 04/2018 - 09/2012
7	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2024 - 07/2004
7	Ifosfamide FDA LinkGeneric 11/2022 - 05/2005
7	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2014
6	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 09/2022 - 03/2015
5	pazopanib FDA Link 03/2023 - 03/2016
5	Denosumab FDA Link 09/2022 - 03/2017
5	Methylnitronitrosoguanidine (MNNG)IBA 01/2021 - 01/2003
4	Indicators and Reagents (Reagents)IBA 04/2024 - 04/2011
4	EnzymesIBA 01/2024 - 07/2004
4	CytokinesIBA 07/2023 - 01/2015
4	TeaIBA 01/2023 - 01/2014
4	LigandsIBA 05/2022 - 03/2017
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
4	A-factor (Streptomyces)IBA 05/2017 - 01/2015
3	TitaniumIBA 04/2024 - 03/2016
3	MMEIBA 01/2024 - 11/2021
3	Immune Checkpoint InhibitorsIBA 11/2023 - 04/2021
3	eribulin FDA Link 03/2023 - 01/2017
3	Messenger RNA (mRNA)IBA 02/2023 - 04/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 05/2005
3	NivolumabIBA 04/2021 - 01/2018
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2019 - 03/2015
2	Phosphotransferases (Kinase)IBA 03/2024 - 03/2002
2	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 01/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2024 - 11/2021
2	adenovirus receptorIBA 01/2024 - 04/2011
2	Green Fluorescent ProteinsIBA 01/2024 - 02/2020
2	Transcription Factors (Transcription Factor)IBA 07/2023 - 03/2013
2	Therapeutic UsesIBA 07/2023 - 02/2022
2	TrabectedinIBA 03/2023 - 05/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 06/2006
2	SteroidsIBA 02/2023 - 11/2019

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 11/2023 - 02/2002
25	Therapeutics 04/2024 - 01/2003
20	Radiotherapy 01/2024 - 01/2003
13	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2023 - 05/2003
10	Arthroplasty 02/2024 - 01/2014
8	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2023 - 01/2015
8	Curettage 09/2022 - 08/2002
7	Pedicle Screws 04/2022 - 12/2007
6	Oncolytic Virotherapy 04/2024 - 04/2011
6	Osteotomy 05/2022 - 08/2009
5	Activities of Daily Living (ADL) 02/2024 - 06/2011
5	Adjuvant Chemotherapy 11/2023 - 02/2021
5	Aftercare (After-Treatment) 01/2023 - 03/2015
5	Surgical Amputation (Amputations) 08/2022 - 03/2002
5	Immunotherapy 05/2021 - 01/2015
4	Sutures (Suture) 01/2024 - 01/2019
4	Intramedullary Fracture Fixation 06/2022 - 07/2021
4	Neoadjuvant Therapy 10/2021 - 07/2008
4	Laminoplasty 01/2016 - 05/2007
4	Decompression 01/2014 - 09/2008
3	Reoperation 01/2023 - 02/2017
3	Arthrodesis 05/2022 - 01/2016
3	Operative Surgical Procedures 01/2022 - 04/2020
3	Conservative Treatment 11/2019 - 10/2013
3	Laminectomy 01/2014 - 02/2006